Theodoraki Aikaterini, Vanderpump Mark P J
Department of Endocrinology, Royal Free London NHS Foundation Trust, London, UK.
Clin Endocrinol (Oxf). 2016 Feb;84(2):172-176. doi: 10.1111/cen.12988.
Amiodarone is an anti-arrhythmic drug that commonly affects the thyroid, causing hypothyroidism or thyrotoxicosis. Amiodarone-induced thyrotoxicosis (AIT) is caused by excessive thyroid hormone biosynthesis in response to iodine load in autonomously functioning thyroid glands with pre-existing nodular goitre or underlying Graves' disease (type 1 or AIT 1), or by a destructive thyroiditis typically occurring in normal glands (type 2 or AIT 2). Indeterminate or mixed forms are also recognized. The distinction is clinically useful as AIT 1 is treated predominantly with thionamides, whereas AIT 2 is managed with glucocorticoids. We review the tools used to differentiate type 1 from type 2 thyrotoxicosis, with specific reference to the imaging modalities used.
胺碘酮是一种抗心律失常药物,通常会影响甲状腺,导致甲状腺功能减退或甲状腺毒症。胺碘酮诱发的甲状腺毒症(AIT)是由于自主功能的甲状腺腺体(存在结节性甲状腺肿或潜在格雷夫斯病)对碘负荷反应过度甲状腺激素生物合成所致(1型或AIT 1),或由通常发生在正常腺体的破坏性甲状腺炎引起(2型或AIT 2)。也认识到存在不确定或混合形式。这种区分在临床上很有用,因为AIT 1主要用硫代酰胺治疗,而AIT 2则用糖皮质激素治疗。我们回顾了用于区分1型和2型甲状腺毒症的工具,特别提及所使用的成像方式。